Exabis Library
Welcome to the e-CCO Library!
When do we really know the safety profile of a drug?
2021
ECCO'21 Virtual
Friday, 1 October 2021, 12:41 PM
When IUS, when MRI in daily IBD practice? (Tandem talk)
2020
2nd ECCO-ESGAR Basic Imaging Workshop
Tuesday, 23 June 2020, 5:40 PM
When IUS, when MRI in daily IBD practice? (Tandem talk)
2020
2nd ECCO-ESGAR Basic Imaging Workshop
Tuesday, 23 June 2020, 4:58 PM
1
When the growing gets tough
2022
9th P-ECCO Educational Course - Paediatric IBD: When the going gets tough
Tuesday, 24 May 2022, 8:13 PM
When to stop Biologics in IBD
2016
Talking Heads
Friday, 22 February 2019, 4:17 PM by ECCO Administrator
Friday, 13 January 2023, 11:51 AM by ECCO Administrator
Where is the unmet need for patients with IBD?
2020
5th Basic ECCO: EduCational COurse for Industry
Tuesday, 23 June 2020, 4:58 PM
1
Where is the unmet need for patients with IBD?
2018
4th Basic ECCO: EduCational Course for Industry
Tuesday, 8 May 2018, 11:36 AM
1
Will emerging diets replace medical therapy in IBD? (Tandem Talk)
2021
6th D-ECCO Workshop
Friday, 1 October 2021, 12:41 PM
Will the revolution of OMICs translate into a better care?
2022
ECCO'22 Virtual
Tuesday, 24 May 2022, 8:13 PM
Withdrawal of infliximab or anti-metabolite therapy in Crohn’s Disease patients in sustained remission on combination therapy: A randomized unblinded controlled trial (SPARE)
2022
ECCO'22 Virtual
Tuesday, 24 May 2022, 8:13 PM
Workshop 1 – UC Management (Group A)
2017
8th N-ECCO School
Wednesday, 15 March 2017, 1:52 PM by Vesna Babaja
1
Workshop 2 – CD Management (Group B)
2017
8th N-ECCO School
Wednesday, 15 March 2017, 1:49 PM by Vesna Babaja
1
Y-ECCO Literature Review: 3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomized trial.
2011
ECCO News Issue 2/2011
Monday, 25 February 2019, 1:01 PM by ECCO Administrator
Monday, 25 February 2019, 1:01 PM by ECCO Administrator
1